April 15, 2021
View from Brussels
30
4
European Group on Ethics in Science and New Technologies issues cautious opinion on the use of gene editing amidst COVID vaccination controversy.
April 15, 2021
From the Editor
30
4
Behind-the-scenes look at vaccine development.
April 15, 2021
Issue PDF
30
4
Click the title above for a link to open the Applied Clinical Trials April 2021 issue in an interactive PDF format.
April 15, 2021
A Closing Thought
30
4
Growing availability of RWD leads new drug development process.
April 15, 2021
Feature Articles
30
4
How asking better questions and leveraging site databases can expand access to more patients.
April 15, 2021
Clinical Trial Insights
30
4
Compression between phases to accelerate cycle time.
April 15, 2021
News
30
4
New BDO CRO Insights Report reveals high rate of CRA turnover and what organizations are doing to combat it.
April 15, 2021
Q&A
30
4
Steven Bukvic, CEO of the ACROSS Global Alliance, speaks to Applied Clinical Trials about how it works to improve the clinical trial experience for smaller- and medium-sized sponsors.
March 25, 2021
View from Washington
30
4
FDA is reviewing the record of its accelerated approval program following recent withdrawals of certain key indications for several leading cancer therapies, based on the failure of post-approval studies to document extended benefits of treatment.
March 22, 2021
Feature Articles
30
4
Identifying the ‘significant six’ areas of clinical study conduct to mitigate risk.
March 22, 2021
View from Brussels
30
4
A new partnership, to be known as EP PerMed, aims to bring public and private sector interests together.